378 related articles for article (PubMed ID: 24042196)
1. Differential expression of the tumor suppressor A-kinase anchor protein 12 in human diffuse and pilocytic astrocytomas is regulated by promoter methylation.
Goeppert B; Schmidt CR; Geiselhart L; Dutruel C; Capper D; Renner M; Vogel MN; Zachskorn C; Zinke J; Campos B; Schmezer P; Popanda O; Wick W; Weller M; Meyermann R; Schittenhelm J; Harter PN; Simon P; Weichert W; Schirmacher P; Plass C; Mittelbronn M
J Neuropathol Exp Neurol; 2013 Oct; 72(10):933-41. PubMed ID: 24042196
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of tumor suppressor A kinase anchor protein 12 in human hepatocarcinogenesis by epigenetic mechanisms.
Goeppert B; Schmezer P; Dutruel C; Oakes C; Renner M; Breinig M; Warth A; Vogel MN; Mittelbronn M; Mehrabi A; Gdynia G; Penzel R; Longerich T; Breuhahn K; Popanda O; Plass C; Schirmacher P; Kern MA
Hepatology; 2010 Dec; 52(6):2023-33. PubMed ID: 20979053
[TBL] [Abstract][Full Text] [Related]
3. Identification of the A kinase anchor protein 12 (AKAP12) gene as a candidate tumor suppressor of hepatocellular carcinoma.
Hayashi M; Nomoto S; Kanda M; Okamura Y; Nishikawa Y; Yamada S; Fujii T; Sugimoto H; Takeda S; Kodera Y
J Surg Oncol; 2012 Mar; 105(4):381-6. PubMed ID: 22052684
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic silencing of AKAP12 in juvenile myelomonocytic leukemia.
Wilhelm T; Lipka DB; Witte T; Wierzbinska JA; Fluhr S; Helf M; Mücke O; Claus R; Konermann C; Nöllke P; Niemeyer CM; Flotho C; Plass C
Epigenetics; 2016; 11(2):110-9. PubMed ID: 26891149
[TBL] [Abstract][Full Text] [Related]
5. Promoter hypermethylation-mediated down-regulation of CXCL12 in human astrocytoma.
Zhou W; Jiang Z; Song X; Liu Y; Wen P; Guo Y; Xu F; Kong L; Zhang P; Han A; Yu J
J Neurosci Res; 2008 Oct; 86(13):3002-10. PubMed ID: 18512766
[TBL] [Abstract][Full Text] [Related]
6. Quantitative assessment of AKAP12 promoter methylation in human prostate cancer using methylation-sensitive high-resolution melting: correlation with Gleason score.
Liu W; Gong J; Hu J; Hu T; Sun Y; Du J; Sun C; Guan M; Jiang H; Lu Y
Urology; 2011 Apr; 77(4):1006.e1-7. PubMed ID: 21310466
[TBL] [Abstract][Full Text] [Related]
7. DNA methylation analysis of paediatric low-grade astrocytomas identifies a tumour-specific hypomethylation signature in pilocytic astrocytomas.
Jeyapalan JN; Doctor GT; Jones TA; Alberman SN; Tep A; Haria CM; Schwalbe EC; Morley IC; Hill AA; LeCain M; Ottaviani D; Clifford SC; Qaddoumi I; Tatevossian RG; Ellison DW; Sheer D
Acta Neuropathol Commun; 2016 May; 4(1):54. PubMed ID: 27229157
[TBL] [Abstract][Full Text] [Related]
8. AKAP12, a gene with tumour suppressor properties, is a target of promoter DNA methylation in childhood myeloid malignancies.
Flotho C; Paulun A; Batz C; Niemeyer CM
Br J Haematol; 2007 Sep; 138(5):644-50. PubMed ID: 17686059
[TBL] [Abstract][Full Text] [Related]
9. Promoter hypermethylation of multiple genes in astrocytic gliomas.
Gonzalez-Gomez P; Bello MJ; Arjona D; Lomas J; Alonso ME; De Campos JM; Vaquero J; Isla A; Gutierrez M; Rey JA
Int J Oncol; 2003 Mar; 22(3):601-8. PubMed ID: 12579314
[TBL] [Abstract][Full Text] [Related]
10. Methylation of AKAP12{alpha} promoter in lung cancer.
Jo UH; Whang YM; Sung JS; Kim YH
Anticancer Res; 2010 Nov; 30(11):4595-600. PubMed ID: 21115911
[TBL] [Abstract][Full Text] [Related]
11. Exploring the distinctive biological characteristics of pilocytic and low-grade diffuse astrocytomas using microarray gene expression profiles.
Rorive S; Maris C; Debeir O; Sandras F; Vidaud M; Bièche I; Salmon I; Decaestecker C
J Neuropathol Exp Neurol; 2006 Aug; 65(8):794-807. PubMed ID: 16896313
[TBL] [Abstract][Full Text] [Related]
12. Combined molecular analysis of BRAF and IDH1 distinguishes pilocytic astrocytoma from diffuse astrocytoma.
Korshunov A; Meyer J; Capper D; Christians A; Remke M; Witt H; Pfister S; von Deimling A; Hartmann C
Acta Neuropathol; 2009 Sep; 118(3):401-5. PubMed ID: 19543740
[TBL] [Abstract][Full Text] [Related]
13. WT1 expression increases with malignancy and indicates unfavourable outcome in astrocytoma.
Rauscher J; Beschorner R; Gierke M; Bisdas S; Braun C; Ebner FH; Schittenhelm J
J Clin Pathol; 2014 Jul; 67(7):556-61. PubMed ID: 24607494
[TBL] [Abstract][Full Text] [Related]
14. Promoter hypermethylation-mediated down-regulation of LATS1 and LATS2 in human astrocytoma.
Jiang Z; Li X; Hu J; Zhou W; Jiang Y; Li G; Lu D
Neurosci Res; 2006 Dec; 56(4):450-8. PubMed ID: 17049657
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic changes in pilocytic astrocytomas and medulloblastomas.
Gonzalez-Gomez P; Bello MJ; Lomas J; Arjona D; Alonso ME; Amiñoso C; De Campos JM; Vaquero J; Sarasa JL; Casartelli C; Rey JA
Int J Mol Med; 2003 May; 11(5):655-60. PubMed ID: 12684707
[TBL] [Abstract][Full Text] [Related]
16. Pilocytic astrocytoma of the optic pathway: a tumour deriving from radial glia cells with a specific gene signature.
Tchoghandjian A; Fernandez C; Colin C; El Ayachi I; Voutsinos-Porche B; Fina F; Scavarda D; Piercecchi-Marti MD; Intagliata D; Ouafik L; Fraslon-Vanhulle C; Figarella-Branger D
Brain; 2009 Jun; 132(Pt 6):1523-35. PubMed ID: 19336457
[TBL] [Abstract][Full Text] [Related]
17. High frequency of p53 protein accumulation without p53 gene mutation in human juvenile pilocytic, low grade and anaplastic astrocytomas.
Lang FF; Miller DC; Pisharody S; Koslow M; Newcomb EW
Oncogene; 1994 Mar; 9(3):949-54. PubMed ID: 8108140
[TBL] [Abstract][Full Text] [Related]
18. Frequent epigenetic inactivation of the chaperone SGNE1/7B2 in human gliomas.
Waha A; Felsberg J; Hartmann W; Hammes J; von dem Knesebeck A; Endl E; Pietsch T; Waha A
Int J Cancer; 2012 Aug; 131(3):612-22. PubMed ID: 21901745
[TBL] [Abstract][Full Text] [Related]
19. Tenascin-C expression relates to clinicopathological features in pilocytic and diffuse astrocytomas.
Maris C; Rorive S; Sandras F; D'Haene N; Sadeghi N; Bièche I; Vidaud M; Decaestecker C; Salmon I
Neuropathol Appl Neurobiol; 2008 Jun; 34(3):316-29. PubMed ID: 17983425
[TBL] [Abstract][Full Text] [Related]
20. Quantitative assessment of AKAP12 promoter methylation in colorectal cancer using methylation-sensitive high resolution melting: Correlation with Duke's stage.
Liu W; Guan M; Su B; Ye C; Li J; Zhang X; Liu C; Li M; Lin Y; Lu Y
Cancer Biol Ther; 2010 Jun; 9(11):862-71. PubMed ID: 20364105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
